Document is current
Any future updates will be listed below
-
Authors
Svensson, Fredrik https://orcid.org/0000-0002-6630-8820
Felson, David T
Zhang, Fan
Guermazi, Ali
Roemer, Frank W
Niu, Jingbo
Aliabadi, Piran
Neogi, Tuhina
Englund, Martin
-
Funding
Funding for this research was provided by:
National Institutes of Health (AG18393, AR47785)
The Swedish Research Council
The Kock Foundation, Sweden
The Swedish Rheumatism Association
Region Skåne, Sweden
Governmental Funding of Clinical Research within National Health Service (ALF), Sweden
Faculty of Medicine, Lund University, Sweden
- License Information
-
More Information
Article History
Received: 10 July 2017
Revised: 20 September 2017
Accepted: 18 October 2017
First Online: 2 October 2018
Compliance with ethical standards
:
: The scientific guarantor of this publication is Martin Englund.
: The authors of this manuscript declare relationships with the following companies:Dr. Guermazi reports personal fees from MerckSerono, TissueGene, OrthoTrophix, GE Healthcare, AstraZeneca, Pfizer, and Sanofi-Aventis, and personal fees from Boston Imaging Core Lab, LLC, outside the submitted work.Dr. Roemer reports other from Boston Imaging Core Lab. (BICL), LLC, outside the submitted work.Each other author certifies that he or she has no commercial associations (e.g., consultancies, stock ownership, equity interest, patent/licensing arrangements) that might pose a conflict of interest in connection with the submitted article.
: Aleksandra Turkiewicz kindly provided statistical advice for this manuscript.
: Written informed consent was obtained from all subjects (patients) in this study.
: Institutional Review Board approval was obtained.
: • cross-sectional study• multicenter study
